

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | rRNA methylation (GO:0031167) | 5.23734362 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.40656049 |
| 3 | glutamate receptor signaling pathway (GO:0007215) | 4.28165725 |
| 4 | relaxation of cardiac muscle (GO:0055119) | 4.24301844 |
| 5 | negative regulation of sodium ion transport (GO:0010766) | 4.23899291 |
| 6 | rRNA modification (GO:0000154) | 4.05671526 |
| 7 | axonal fasciculation (GO:0007413) | 3.75008964 |
| 8 | vocalization behavior (GO:0071625) | 3.74669270 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 3.74138199 |
| 10 | presynaptic membrane assembly (GO:0097105) | 3.73204377 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.66389808 |
| 12 | positive regulation of muscle hypertrophy (GO:0014742) | 3.64063126 |
| 13 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.64063126 |
| 14 | neuron recognition (GO:0008038) | 3.58005559 |
| 15 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.55728123 |
| 16 | negative regulation of hormone metabolic process (GO:0032351) | 3.55728123 |
| 17 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.55194495 |
| 18 | synaptic vesicle endocytosis (GO:0048488) | 3.52757008 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.48666040 |
| 20 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.36416081 |
| 21 | inner ear receptor cell development (GO:0060119) | 3.34842477 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 3.32878609 |
| 23 | innervation (GO:0060384) | 3.32798227 |
| 24 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.31910092 |
| 25 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.31329369 |
| 26 | startle response (GO:0001964) | 3.29821061 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.29422424 |
| 28 | presynaptic membrane organization (GO:0097090) | 3.27012762 |
| 29 | postsynaptic membrane organization (GO:0001941) | 3.26408554 |
| 30 | lens fiber cell differentiation (GO:0070306) | 3.24466035 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.24440439 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.21261600 |
| 33 | righting reflex (GO:0060013) | 3.12639283 |
| 34 | paraxial mesoderm development (GO:0048339) | 3.07526462 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.07340907 |
| 36 | cochlea development (GO:0090102) | 3.05726262 |
| 37 | histone H3-K36 demethylation (GO:0070544) | 3.04941732 |
| 38 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.98787754 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.96443949 |
| 40 | dorsal/ventral axis specification (GO:0009950) | 2.94166192 |
| 41 | serotonin receptor signaling pathway (GO:0007210) | 2.93115581 |
| 42 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.89398383 |
| 43 | behavioral defense response (GO:0002209) | 2.88916312 |
| 44 | behavioral fear response (GO:0001662) | 2.88916312 |
| 45 | long-term synaptic potentiation (GO:0060291) | 2.88532651 |
| 46 | microglial cell activation (GO:0001774) | 2.87753425 |
| 47 | fear response (GO:0042596) | 2.84618231 |
| 48 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.84326045 |
| 49 | proline transport (GO:0015824) | 2.81807388 |
| 50 | response to histamine (GO:0034776) | 2.81034379 |
| 51 | dendritic spine organization (GO:0097061) | 2.76529480 |
| 52 | apical protein localization (GO:0045176) | 2.76409270 |
| 53 | mitotic sister chromatid cohesion (GO:0007064) | 2.74673538 |
| 54 | relaxation of muscle (GO:0090075) | 2.73972853 |
| 55 | asymmetric protein localization (GO:0008105) | 2.73971316 |
| 56 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72380533 |
| 57 | regulation of cell communication by electrical coupling (GO:0010649) | 2.72075541 |
| 58 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.71443971 |
| 59 | embryonic foregut morphogenesis (GO:0048617) | 2.69845668 |
| 60 | glycerophospholipid catabolic process (GO:0046475) | 2.66404950 |
| 61 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.66172669 |
| 62 | regulation of Rac protein signal transduction (GO:0035020) | 2.64236189 |
| 63 | dentate gyrus development (GO:0021542) | 2.62790509 |
| 64 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.62589236 |
| 65 | nuclear pore complex assembly (GO:0051292) | 2.61654034 |
| 66 | regulation of centriole replication (GO:0046599) | 2.58795610 |
| 67 | C4-dicarboxylate transport (GO:0015740) | 2.58308103 |
| 68 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.57867795 |
| 69 | eosinophil chemotaxis (GO:0048245) | 2.57475769 |
| 70 | regulation of bile acid biosynthetic process (GO:0070857) | 2.57184188 |
| 71 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.54893439 |
| 72 | limb bud formation (GO:0060174) | 2.53938755 |
| 73 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.53519057 |
| 74 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.53257022 |
| 75 | negative regulation of dendrite development (GO:2000171) | 2.51577600 |
| 76 | vesicle transport along microtubule (GO:0047496) | 2.51545640 |
| 77 | regulation of Rac GTPase activity (GO:0032314) | 2.51378617 |
| 78 | genitalia morphogenesis (GO:0035112) | 2.51376472 |
| 79 | establishment of nucleus localization (GO:0040023) | 2.51356529 |
| 80 | regulation of postsynaptic membrane potential (GO:0060078) | 2.49883435 |
| 81 | gastrulation with mouth forming second (GO:0001702) | 2.49878216 |
| 82 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.49733372 |
| 83 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.47851632 |
| 84 | striatum development (GO:0021756) | 2.47831499 |
| 85 | nuclear pore organization (GO:0006999) | 2.47019854 |
| 86 | social behavior (GO:0035176) | 2.46411886 |
| 87 | intraspecies interaction between organisms (GO:0051703) | 2.46411886 |
| 88 | dendrite development (GO:0016358) | 2.45720213 |
| 89 | protein localization to synapse (GO:0035418) | 2.45606507 |
| 90 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.45012008 |
| 91 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.44543100 |
| 92 | cartilage morphogenesis (GO:0060536) | 2.44360638 |
| 93 | female mating behavior (GO:0060180) | 2.44141884 |
| 94 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.43315438 |
| 95 | regulation of muscle adaptation (GO:0043502) | 2.43283473 |
| 96 | anterior/posterior axis specification, embryo (GO:0008595) | 2.43143242 |
| 97 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.41588057 |
| 98 | synapse assembly (GO:0007416) | 2.41147974 |
| 99 | exploration behavior (GO:0035640) | 2.40274428 |
| 100 | transmission of nerve impulse (GO:0019226) | 2.40095594 |
| 101 | glycosphingolipid biosynthetic process (GO:0006688) | 2.39994636 |
| 102 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.39332611 |
| 103 | multicellular organismal reproductive behavior (GO:0033057) | 2.39225600 |
| 104 | regulation of centrosome duplication (GO:0010824) | 2.36805533 |
| 105 | multicellular organismal signaling (GO:0035637) | 2.35638948 |
| 106 | negative regulation of histone acetylation (GO:0035067) | 2.35553799 |
| 107 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.35184099 |
| 108 | histone H3-K9 demethylation (GO:0033169) | 2.35084076 |
| 109 | prostate gland growth (GO:0060736) | 2.34631173 |
| 110 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34239013 |
| 111 | regulation of muscle hypertrophy (GO:0014743) | 2.34203571 |
| 112 | central nervous system neuron axonogenesis (GO:0021955) | 2.33550910 |
| 113 | eye photoreceptor cell differentiation (GO:0001754) | 2.33062543 |
| 114 | photoreceptor cell differentiation (GO:0046530) | 2.33062543 |
| 115 | serotonin metabolic process (GO:0042428) | 2.32126999 |
| 116 | regulation of female receptivity (GO:0045924) | 2.31922176 |
| 117 | nucleus localization (GO:0051647) | 2.31600549 |
| 118 | positive regulation of response to oxidative stress (GO:1902884) | 2.30055141 |
| 119 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.30055141 |
| 120 | base-excision repair, AP site formation (GO:0006285) | 2.29191163 |
| 121 | positive regulation of vesicle fusion (GO:0031340) | 2.29132655 |
| 122 | vascular smooth muscle contraction (GO:0014829) | 2.26030217 |
| 123 | intraciliary transport (GO:0042073) | 2.25710188 |
| 124 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.24894404 |
| 125 | hippo signaling (GO:0035329) | 2.20139396 |
| 126 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.16989015 |
| 127 | establishment of protein localization to Golgi (GO:0072600) | 2.15438905 |
| 128 | protein targeting to Golgi (GO:0000042) | 2.15172766 |
| 129 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.14245755 |
| 130 | positive regulation of male gonad development (GO:2000020) | 2.10472616 |
| 131 | regulation of sulfur metabolic process (GO:0042762) | 2.09412206 |
| 132 | COPII vesicle coating (GO:0048208) | 2.09382547 |
| 133 | neural tube formation (GO:0001841) | 2.08686324 |
| 134 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.07669839 |
| 135 | ephrin receptor signaling pathway (GO:0048013) | 2.07402041 |
| 136 | notochord development (GO:0030903) | 2.07014556 |
| 137 | regulation of keratinocyte proliferation (GO:0010837) | 2.06172743 |
| 138 | olfactory bulb development (GO:0021772) | 2.05940365 |
| 139 | short-term memory (GO:0007614) | 2.05794523 |
| 140 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.03423324 |
| 141 | ectodermal placode formation (GO:0060788) | 2.00535346 |
| 142 | gap junction assembly (GO:0016264) | 2.00341036 |
| 143 | retina layer formation (GO:0010842) | 1.99600909 |
| 144 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.99247571 |
| 145 | membrane budding (GO:0006900) | 1.97934587 |
| 146 | cerebral cortex cell migration (GO:0021795) | 1.97085097 |
| 147 | regulation of centrosome cycle (GO:0046605) | 1.96539868 |
| 148 | positive regulation of glycoprotein metabolic process (GO:1903020) | 1.96078618 |
| 149 | glial cell proliferation (GO:0014009) | 1.95944004 |
| 150 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 1.95855924 |
| 151 | NLS-bearing protein import into nucleus (GO:0006607) | 1.94703347 |
| 152 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 1.94199392 |
| 153 | cytoplasmic mRNA processing body assembly (GO:0033962) | 1.93941068 |
| 154 | labyrinthine layer development (GO:0060711) | 1.93502397 |
| 155 | Leydig cell differentiation (GO:0033327) | 1.93345726 |
| 156 | membrane assembly (GO:0071709) | 1.92897567 |
| 157 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.91060051 |
| 158 | nonmotile primary cilium assembly (GO:0035058) | 1.90719838 |
| 159 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.90602750 |
| 160 | desmosome organization (GO:0002934) | 1.90506325 |
| 161 | endoplasmic reticulum organization (GO:0007029) | 1.89963747 |
| 162 | myelin assembly (GO:0032288) | 1.88064501 |
| 163 | fibroblast migration (GO:0010761) | 1.87297316 |
| 164 | organelle transport along microtubule (GO:0072384) | 1.87101052 |
| 165 | regulation of coenzyme metabolic process (GO:0051196) | 1.87004869 |
| 166 | regulation of cofactor metabolic process (GO:0051193) | 1.87004869 |
| 167 | regulation of growth hormone secretion (GO:0060123) | 1.85793947 |
| 168 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 1.84674248 |
| 169 | cellular sodium ion homeostasis (GO:0006883) | 1.84215707 |
| 170 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 1.83562761 |
| 171 | dendrite morphogenesis (GO:0048813) | 1.82816645 |
| 172 | protein heterotetramerization (GO:0051290) | 1.81728537 |
| 173 | anterior/posterior axis specification (GO:0009948) | 1.81659750 |
| 174 | Golgi to plasma membrane protein transport (GO:0043001) | 1.81076414 |
| 175 | negative regulation of DNA recombination (GO:0045910) | 1.81005325 |
| 176 | peptidyl-lysine dimethylation (GO:0018027) | 1.80702151 |
| 177 | Golgi to endosome transport (GO:0006895) | 1.79970311 |
| 178 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.79884412 |
| 179 | cellular response to sterol (GO:0036315) | 1.79759449 |
| 180 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 1.79440322 |
| 181 | retinal ganglion cell axon guidance (GO:0031290) | 1.78563682 |
| 182 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 1.78355075 |
| 183 | regulation of myelination (GO:0031641) | 1.78131349 |
| 184 | negative regulation of JUN kinase activity (GO:0043508) | 1.77835893 |
| 185 | regulation of protein glycosylation (GO:0060049) | 1.77601760 |
| 186 | cell adhesion mediated by integrin (GO:0033627) | 1.76857568 |
| 187 | regulation of axon guidance (GO:1902667) | 1.76763990 |
| 188 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 1.76553657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.74920907 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.70294929 |
| 3 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.76551752 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37308711 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.34298203 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32915654 |
| 7 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.24376851 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23831179 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18734733 |
| 10 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.17160030 |
| 11 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.07973787 |
| 12 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.04073357 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.00836547 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.97167596 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96143834 |
| 16 | TP53_16413492_ChIP-PET_HCT116_Human | 1.92678916 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.92150483 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87619144 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86887964 |
| 20 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.83517879 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82127670 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81979954 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81622433 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80794532 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79301095 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79062836 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78947939 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.78441654 |
| 29 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.77528246 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76033476 |
| 31 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.73408955 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73183165 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72769034 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72651780 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69552524 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67289687 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64918751 |
| 38 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63768906 |
| 39 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.63510895 |
| 40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.63510895 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62386623 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61545075 |
| 43 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.59335538 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.56439145 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56383626 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56328919 |
| 47 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.56266556 |
| 48 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.55196342 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.52887460 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52697498 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50750604 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50744377 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50084609 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49584191 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49504344 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48658080 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47793330 |
| 58 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.46327030 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46258597 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46096929 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43928612 |
| 62 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.43338946 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43336722 |
| 64 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43336722 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42092981 |
| 66 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.40608308 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40221730 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39865719 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39659488 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39434754 |
| 71 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38948787 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.38663851 |
| 73 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36275937 |
| 74 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36245078 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34961491 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.34735031 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34425340 |
| 78 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33839152 |
| 79 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.33669786 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33505331 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33406047 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32867271 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30593192 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30581904 |
| 85 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.30423676 |
| 86 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30373963 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30151150 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29441698 |
| 89 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.29271653 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28767563 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28442755 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.27839071 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27746468 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27564451 |
| 95 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27002722 |
| 96 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26633971 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.25283715 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25155028 |
| 99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24013867 |
| 100 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23924532 |
| 101 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23833669 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.23704046 |
| 103 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.21583538 |
| 104 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21156235 |
| 105 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20283650 |
| 106 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20200578 |
| 107 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17872825 |
| 108 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17386734 |
| 109 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.17313985 |
| 110 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.17133463 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16377102 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16377102 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16134534 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15861982 |
| 115 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15620035 |
| 116 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.15210775 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14786162 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14745010 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14425177 |
| 120 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14114747 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12347977 |
| 122 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12276977 |
| 123 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.11705631 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11377869 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11239560 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10465544 |
| 127 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10389643 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10039256 |
| 129 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10039256 |
| 130 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09981216 |
| 131 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09793406 |
| 132 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08517221 |
| 133 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07754295 |
| 134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07454311 |
| 135 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07148842 |
| 136 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06904589 |
| 137 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03803289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.32312752 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.84244478 |
| 3 | MP0003787_abnormal_imprinting | 3.13133669 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.03432734 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.82191371 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.76909358 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.65733887 |
| 8 | MP0001188_hyperpigmentation | 2.61416008 |
| 9 | MP0002736_abnormal_nociception_after | 2.47053455 |
| 10 | MP0009745_abnormal_behavioral_response | 2.41457512 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.40922967 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.40091001 |
| 13 | MP0000778_abnormal_nervous_system | 2.37535335 |
| 14 | MP0002254_reproductive_system_inflammat | 2.34426846 |
| 15 | MP0004270_analgesia | 2.29526978 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.25341820 |
| 17 | MP0002102_abnormal_ear_morphology | 2.14319437 |
| 18 | MP0003136_yellow_coat_color | 2.12448340 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.12177309 |
| 20 | MP0001486_abnormal_startle_reflex | 2.05147388 |
| 21 | MP0000566_synostosis | 2.01522366 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.93712400 |
| 23 | MP0002064_seizures | 1.93516631 |
| 24 | MP0000569_abnormal_digit_pigmentation | 1.86099740 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.84694939 |
| 26 | MP0001299_abnormal_eye_distance/ | 1.84604397 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.80197641 |
| 28 | MP0001984_abnormal_olfaction | 1.75213552 |
| 29 | MP0002638_abnormal_pupillary_reflex | 1.70786311 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.69817410 |
| 31 | MP0004272_abnormal_basement_membrane | 1.68407736 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.64653953 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.61257169 |
| 34 | MP0002233_abnormal_nose_morphology | 1.58833259 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.58532963 |
| 36 | MP0000538_abnormal_urinary_bladder | 1.57118737 |
| 37 | MP0009697_abnormal_copulation | 1.55687490 |
| 38 | MP0000647_abnormal_sebaceous_gland | 1.53218687 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.51813195 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.50711985 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.49468634 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.47831663 |
| 43 | MP0005171_absent_coat_pigmentation | 1.46826485 |
| 44 | MP0001293_anophthalmia | 1.45852872 |
| 45 | MP0003868_abnormal_feces_composition | 1.44212285 |
| 46 | MP0003941_abnormal_skin_development | 1.43534876 |
| 47 | MP0001529_abnormal_vocalization | 1.43382424 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.43100997 |
| 49 | MP0004924_abnormal_behavior | 1.43100997 |
| 50 | MP0002272_abnormal_nervous_system | 1.42450892 |
| 51 | MP0002184_abnormal_innervation | 1.42063054 |
| 52 | MP0004484_altered_response_of | 1.41576682 |
| 53 | MP0003121_genomic_imprinting | 1.41128122 |
| 54 | MP0002697_abnormal_eye_size | 1.35030364 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.32030940 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.30685416 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.30038226 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.29838663 |
| 59 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28313787 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.28154468 |
| 61 | MP0009046_muscle_twitch | 1.20681831 |
| 62 | MP0008057_abnormal_DNA_replication | 1.20375849 |
| 63 | MP0004885_abnormal_endolymph | 1.19068472 |
| 64 | MP0001286_abnormal_eye_development | 1.18542365 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.17947483 |
| 66 | MP0005367_renal/urinary_system_phenotyp | 1.16873235 |
| 67 | MP0000516_abnormal_urinary_system | 1.16873235 |
| 68 | MP0002084_abnormal_developmental_patter | 1.15406005 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.14418421 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.13398775 |
| 71 | MP0004883_abnormal_blood_vessel | 1.12711367 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.12083873 |
| 73 | MP0003755_abnormal_palate_morphology | 1.11994278 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.11465419 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.10879898 |
| 76 | MP0000383_abnormal_hair_follicle | 1.08719384 |
| 77 | MP0001177_atelectasis | 1.08618851 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.08406221 |
| 79 | MP0006054_spinal_hemorrhage | 1.06282902 |
| 80 | MP0002163_abnormal_gland_morphology | 1.05757729 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.04790293 |
| 82 | MP0009703_decreased_birth_body | 1.04660897 |
| 83 | MP0002733_abnormal_thermal_nociception | 1.04457159 |
| 84 | MP0004215_abnormal_myocardial_fiber | 1.04099626 |
| 85 | MP0000428_abnormal_craniofacial_morphol | 1.01451877 |
| 86 | MP0003119_abnormal_digestive_system | 1.01306905 |
| 87 | MP0002092_abnormal_eye_morphology | 0.99608352 |
| 88 | MP0002882_abnormal_neuron_morphology | 0.97329208 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.97237697 |
| 90 | MP0002249_abnormal_larynx_morphology | 0.96885983 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.95746375 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.95706602 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.95684632 |
| 94 | MP0003935_abnormal_craniofacial_develop | 0.94416115 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.94007971 |
| 96 | MP0002090_abnormal_vision | 0.93911813 |
| 97 | MP0000462_abnormal_digestive_system | 0.93901850 |
| 98 | MP0001919_abnormal_reproductive_system | 0.92530737 |
| 99 | MP0000026_abnormal_inner_ear | 0.92234259 |
| 100 | MP0003632_abnormal_nervous_system | 0.92011848 |
| 101 | MP0001905_abnormal_dopamine_level | 0.91742180 |
| 102 | MP0002152_abnormal_brain_morphology | 0.91529882 |
| 103 | MP0000762_abnormal_tongue_morphology | 0.91407902 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.90884802 |
| 105 | MP0000432_abnormal_head_morphology | 0.90702233 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.90291160 |
| 107 | MP0003252_abnormal_bile_duct | 0.89948213 |
| 108 | MP0005275_abnormal_skin_tensile | 0.89947022 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.89267085 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88595372 |
| 111 | MP0005253_abnormal_eye_physiology | 0.88551772 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86884732 |
| 113 | MP0005391_vision/eye_phenotype | 0.86554774 |
| 114 | MP0005423_abnormal_somatic_nervous | 0.86043013 |
| 115 | MP0005408_hypopigmentation | 0.85770529 |
| 116 | MP0001970_abnormal_pain_threshold | 0.85078343 |
| 117 | MP0005187_abnormal_penis_morphology | 0.84358173 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.84267261 |
| 119 | MP0003195_calcinosis | 0.83481159 |
| 120 | MP0000955_abnormal_spinal_cord | 0.83283233 |
| 121 | MP0002751_abnormal_autonomic_nervous | 0.82484872 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.82292147 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.82046486 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.81912739 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.80326891 |
| 126 | MP0000427_abnormal_hair_cycle | 0.80242509 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.80081554 |
| 128 | MP0004858_abnormal_nervous_system | 0.79676107 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.79551093 |
| 130 | MP0003937_abnormal_limbs/digits/tail_de | 0.79507634 |
| 131 | MP0003718_maternal_effect | 0.79357725 |
| 132 | MP0005310_abnormal_salivary_gland | 0.79325746 |
| 133 | MP0003115_abnormal_respiratory_system | 0.78905315 |
| 134 | MP0002822_catalepsy | 0.78671895 |
| 135 | MP0002234_abnormal_pharynx_morphology | 0.78054705 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.77986745 |
| 137 | MP0003631_nervous_system_phenotype | 0.77750162 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.77672729 |
| 139 | MP0005197_abnormal_uvea_morphology | 0.77610486 |
| 140 | MP0003385_abnormal_body_wall | 0.74808078 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.74145382 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.72742160 |
| 143 | MP0002177_abnormal_outer_ear | 0.72626305 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.72467309 |
| 145 | MP0003122_maternal_imprinting | 0.72342083 |
| 146 | MP0003942_abnormal_urinary_system | 0.71643411 |
| 147 | MP0003633_abnormal_nervous_system | 0.71401629 |
| 148 | MP0002009_preneoplasia | 0.71282736 |
| 149 | MP0005365_abnormal_bile_salt | 0.70271943 |
| 150 | MP0001340_abnormal_eyelid_morphology | 0.70149585 |
| 151 | MP0004742_abnormal_vestibular_system | 0.69321518 |
| 152 | MP0000681_abnormal_thyroid_gland | 0.68998821 |
| 153 | MP0003861_abnormal_nervous_system | 0.68624840 |
| 154 | MP0002168_other_aberrant_phenotype | 0.68559846 |
| 155 | MP0002111_abnormal_tail_morphology | 0.67783778 |
| 156 | MP0001915_intracranial_hemorrhage | 0.67782893 |
| 157 | MP0002127_abnormal_cardiovascular_syste | 0.67688886 |
| 158 | MP0002938_white_spotting | 0.66301207 |
| 159 | MP0002269_muscular_atrophy | 0.64920321 |
| 160 | MP0000639_abnormal_adrenal_gland | 0.63408818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.95086136 |
| 2 | Febrile seizures (HP:0002373) | 4.54881785 |
| 3 | Atonic seizures (HP:0010819) | 3.70894554 |
| 4 | Oligodactyly (hands) (HP:0001180) | 3.49750472 |
| 5 | Generalized hypopigmentation of hair (HP:0011358) | 3.40093988 |
| 6 | Abnormality of the labia minora (HP:0012880) | 3.29163971 |
| 7 | Focal seizures (HP:0007359) | 3.25546701 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 3.15944309 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.13171280 |
| 10 | Absent frontal sinuses (HP:0002688) | 3.11429355 |
| 11 | Protruding tongue (HP:0010808) | 3.10603196 |
| 12 | Fair hair (HP:0002286) | 3.07006092 |
| 13 | Excessive salivation (HP:0003781) | 3.05124763 |
| 14 | Drooling (HP:0002307) | 3.05124763 |
| 15 | Absent speech (HP:0001344) | 2.93557422 |
| 16 | Asymmetry of the thorax (HP:0001555) | 2.87665857 |
| 17 | Thyroid carcinoma (HP:0002890) | 2.83537448 |
| 18 | Tubulointerstitial nephritis (HP:0001970) | 2.83361667 |
| 19 | Arterial tortuosity (HP:0005116) | 2.78436839 |
| 20 | Hyperventilation (HP:0002883) | 2.77562614 |
| 21 | Hepatoblastoma (HP:0002884) | 2.69913939 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 2.68743885 |
| 23 | Chronic hepatic failure (HP:0100626) | 2.66412843 |
| 24 | Absence seizures (HP:0002121) | 2.63469669 |
| 25 | Aplasia involving bones of the extremities (HP:0009825) | 2.62687683 |
| 26 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.62687683 |
| 27 | Aplasia of the phalanges of the hand (HP:0009802) | 2.62687683 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.58547851 |
| 29 | Vertebral arch anomaly (HP:0008438) | 2.43176814 |
| 30 | Broad-based gait (HP:0002136) | 2.42973097 |
| 31 | Blue irides (HP:0000635) | 2.41759162 |
| 32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.39840140 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.39840140 |
| 34 | Urethral obstruction (HP:0000796) | 2.39733843 |
| 35 | Bifid tongue (HP:0010297) | 2.35099506 |
| 36 | Fibular aplasia (HP:0002990) | 2.31826325 |
| 37 | Exotropia (HP:0000577) | 2.31318640 |
| 38 | Inappropriate behavior (HP:0000719) | 2.26837224 |
| 39 | Spondylolisthesis (HP:0003302) | 2.26769064 |
| 40 | Aqueductal stenosis (HP:0002410) | 2.25549511 |
| 41 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.24643682 |
| 42 | Abnormality of the corticospinal tract (HP:0002492) | 2.23524403 |
| 43 | Renal cortical cysts (HP:0000803) | 2.22305147 |
| 44 | Dialeptic seizures (HP:0011146) | 2.21439926 |
| 45 | Progressive sensorineural hearing impairment (HP:0000408) | 2.21290070 |
| 46 | Agnosia (HP:0010524) | 2.20201074 |
| 47 | Vascular tortuosity (HP:0004948) | 2.19881720 |
| 48 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.17797120 |
| 49 | Abnormality of the axillary hair (HP:0100134) | 2.15861204 |
| 50 | Abnormality of secondary sexual hair (HP:0009888) | 2.15861204 |
| 51 | Genital tract atresia (HP:0001827) | 2.15757411 |
| 52 | Abnormality of salivation (HP:0100755) | 2.15414853 |
| 53 | Glomerulonephritis (HP:0000099) | 2.14735276 |
| 54 | Chin dimple (HP:0010751) | 2.13997105 |
| 55 | Retinal atrophy (HP:0001105) | 2.13977889 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.13019766 |
| 57 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.12838490 |
| 58 | Vaginal atresia (HP:0000148) | 2.12007600 |
| 59 | Amblyopia (HP:0000646) | 2.11230149 |
| 60 | Action tremor (HP:0002345) | 2.10285244 |
| 61 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.10156355 |
| 62 | Abnormality of the labia (HP:0000058) | 2.09985948 |
| 63 | Syringomyelia (HP:0003396) | 2.08409560 |
| 64 | Spinal cord lesions (HP:0100561) | 2.08409560 |
| 65 | Prostate neoplasm (HP:0100787) | 2.06300885 |
| 66 | Insidious onset (HP:0003587) | 2.04490499 |
| 67 | Termporal pattern (HP:0011008) | 2.04490499 |
| 68 | Facial hemangioma (HP:0000329) | 2.03731600 |
| 69 | Heterochromia iridis (HP:0001100) | 2.02784140 |
| 70 | Scanning speech (HP:0002168) | 2.02151483 |
| 71 | Intestinal atresia (HP:0011100) | 2.02053043 |
| 72 | Widely spaced teeth (HP:0000687) | 2.01346630 |
| 73 | Gait imbalance (HP:0002141) | 2.01318078 |
| 74 | Abnormality of the antihelix (HP:0009738) | 2.00761203 |
| 75 | Complete atrioventricular canal defect (HP:0001674) | 2.00739046 |
| 76 | Abnormality of the frontal sinuses (HP:0002687) | 2.00245162 |
| 77 | Labial hypoplasia (HP:0000066) | 1.99435434 |
| 78 | Biliary tract neoplasm (HP:0100574) | 1.99424100 |
| 79 | Alveolar cell carcinoma (HP:0006519) | 1.99399954 |
| 80 | Hypoplastic labia majora (HP:0000059) | 1.98498619 |
| 81 | Congenital primary aphakia (HP:0007707) | 1.95890048 |
| 82 | Pulmonic stenosis (HP:0001642) | 1.95386261 |
| 83 | Intellectual disability, progressive (HP:0006887) | 1.93102062 |
| 84 | Oligodactyly (HP:0012165) | 1.92159340 |
| 85 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.90375571 |
| 86 | Abnormal biliary tract morphology (HP:0012440) | 1.89230050 |
| 87 | Volvulus (HP:0002580) | 1.89067947 |
| 88 | Urinary urgency (HP:0000012) | 1.87677819 |
| 89 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.87599184 |
| 90 | True hermaphroditism (HP:0010459) | 1.84825353 |
| 91 | Hypothermia (HP:0002045) | 1.84348124 |
| 92 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83595637 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.81819703 |
| 94 | Broad alveolar ridges (HP:0000187) | 1.81312037 |
| 95 | Inability to walk (HP:0002540) | 1.80312839 |
| 96 | Adrenal hypoplasia (HP:0000835) | 1.80126104 |
| 97 | Astrocytoma (HP:0009592) | 1.79845485 |
| 98 | Abnormality of the astrocytes (HP:0100707) | 1.79845485 |
| 99 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79499090 |
| 100 | Poor coordination (HP:0002370) | 1.79135337 |
| 101 | Pheochromocytoma (HP:0002666) | 1.79024388 |
| 102 | Heterotopia (HP:0002282) | 1.78586101 |
| 103 | Occipital encephalocele (HP:0002085) | 1.77951791 |
| 104 | Decreased lacrimation (HP:0000633) | 1.77643899 |
| 105 | Spontaneous abortion (HP:0005268) | 1.77500329 |
| 106 | Nephrogenic diabetes insipidus (HP:0009806) | 1.77109052 |
| 107 | Submucous cleft hard palate (HP:0000176) | 1.76223889 |
| 108 | Abnormality of the labia majora (HP:0012881) | 1.75406349 |
| 109 | Hyperkalemia (HP:0002153) | 1.75345338 |
| 110 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.75334870 |
| 111 | Gastrointestinal carcinoma (HP:0002672) | 1.75334870 |
| 112 | Intrahepatic cholestasis (HP:0001406) | 1.75284337 |
| 113 | Deeply set eye (HP:0000490) | 1.75143544 |
| 114 | Chronic diarrhea (HP:0002028) | 1.73477807 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 1.73292138 |
| 116 | Polyphagia (HP:0002591) | 1.73235776 |
| 117 | Medial flaring of the eyebrow (HP:0010747) | 1.72201445 |
| 118 | Microglossia (HP:0000171) | 1.72109773 |
| 119 | Medulloblastoma (HP:0002885) | 1.71983488 |
| 120 | Fetal akinesia sequence (HP:0001989) | 1.71460248 |
| 121 | Bladder carcinoma (HP:0002862) | 1.70960883 |
| 122 | Bladder neoplasm (HP:0009725) | 1.70960883 |
| 123 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.70573950 |
| 124 | Abnormality of the lower motor neuron (HP:0002366) | 1.70420322 |
| 125 | Absent eyebrow (HP:0002223) | 1.70245415 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69827714 |
| 127 | Curly hair (HP:0002212) | 1.69580334 |
| 128 | Visual hallucinations (HP:0002367) | 1.69229002 |
| 129 | Abnormality of binocular vision (HP:0011514) | 1.68913324 |
| 130 | Diplopia (HP:0000651) | 1.68913324 |
| 131 | Atrioventricular canal defect (HP:0006695) | 1.68740163 |
| 132 | Cutaneous finger syndactyly (HP:0010554) | 1.68526649 |
| 133 | Autism (HP:0000717) | 1.68430151 |
| 134 | Neonatal hypoglycemia (HP:0001998) | 1.68280802 |
| 135 | Aplasia cutis congenita (HP:0001057) | 1.67570826 |
| 136 | Hypoplastic nipples (HP:0002557) | 1.66679750 |
| 137 | Embryonal renal neoplasm (HP:0011794) | 1.66052564 |
| 138 | Hypoplastic female external genitalia (HP:0012815) | 1.65932699 |
| 139 | Anterior segment dysgenesis (HP:0007700) | 1.65891605 |
| 140 | Cortical dysplasia (HP:0002539) | 1.65402901 |
| 141 | Bifid scrotum (HP:0000048) | 1.65349775 |
| 142 | Rhabdomyosarcoma (HP:0002859) | 1.63747657 |
| 143 | Hypoglycemic seizures (HP:0002173) | 1.63614451 |
| 144 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.62772775 |
| 145 | Shawl scrotum (HP:0000049) | 1.62253126 |
| 146 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61991571 |
| 147 | Neoplasm of the small intestine (HP:0100833) | 1.61150945 |
| 148 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.60728652 |
| 149 | Renal hypoplasia (HP:0000089) | 1.60443570 |
| 150 | Cutaneous syndactyly (HP:0012725) | 1.60297657 |
| 151 | Tetraparesis (HP:0002273) | 1.59596064 |
| 152 | Hyperglycinemia (HP:0002154) | 1.58144728 |
| 153 | Alacrima (HP:0000522) | 1.56271953 |
| 154 | Supernumerary spleens (HP:0009799) | 1.55018951 |
| 155 | Short tibia (HP:0005736) | 1.54366057 |
| 156 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.54045870 |
| 157 | Glioma (HP:0009733) | 1.53005001 |
| 158 | Anophthalmia (HP:0000528) | 1.52851327 |
| 159 | Broad foot (HP:0001769) | 1.52343049 |
| 160 | Cubitus valgus (HP:0002967) | 1.52282333 |
| 161 | Abnormality of the nasal septum (HP:0000419) | 1.50297987 |
| 162 | Micropenis (HP:0000054) | 1.49738579 |
| 163 | Median cleft lip (HP:0000161) | 1.48868767 |
| 164 | Double outlet right ventricle (HP:0001719) | 1.47143998 |
| 165 | Congenital malformation of the right heart (HP:0011723) | 1.47143998 |
| 166 | Proximal tubulopathy (HP:0000114) | 1.46669582 |
| 167 | Myelomeningocele (HP:0002475) | 1.45804465 |
| 168 | Midline defect of the nose (HP:0004122) | 1.44379615 |
| 169 | Postaxial hand polydactyly (HP:0001162) | 1.43538247 |
| 170 | Chorioretinal atrophy (HP:0000533) | 1.43477726 |
| 171 | Abnormal sex determination (HP:0012244) | 1.43339809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRD4 | 8.15617634 |
| 2 | MAP3K13 | 3.65123293 |
| 3 | EPHA4 | 3.26935110 |
| 4 | TNIK | 3.04487597 |
| 5 | NTRK3 | 2.95875023 |
| 6 | RIPK4 | 2.77589448 |
| 7 | FRK | 2.70727982 |
| 8 | MAP3K4 | 2.63828971 |
| 9 | TRIM28 | 2.52951266 |
| 10 | STK39 | 2.38403618 |
| 11 | MKNK2 | 2.37687624 |
| 12 | BMPR2 | 2.36585516 |
| 13 | EIF2AK3 | 2.27394863 |
| 14 | MET | 2.22377193 |
| 15 | CASK | 2.04030620 |
| 16 | PBK | 2.03074823 |
| 17 | STK38L | 2.00029724 |
| 18 | MAP2K7 | 1.82638964 |
| 19 | GRK7 | 1.78748562 |
| 20 | MAP3K12 | 1.76753862 |
| 21 | ACVR1B | 1.73602575 |
| 22 | LATS1 | 1.71604416 |
| 23 | MST1R | 1.70921460 |
| 24 | BRSK2 | 1.68751551 |
| 25 | SGK2 | 1.57820498 |
| 26 | CDK9 | 1.57438400 |
| 27 | MAPK13 | 1.54095542 |
| 28 | MAP2K4 | 1.52818950 |
| 29 | MAP3K14 | 1.45043111 |
| 30 | NEK9 | 1.42351155 |
| 31 | EPHA2 | 1.38194850 |
| 32 | NTRK2 | 1.32626760 |
| 33 | PLK2 | 1.29992975 |
| 34 | TSSK6 | 1.29310189 |
| 35 | FGFR1 | 1.28339100 |
| 36 | AKT3 | 1.28240416 |
| 37 | MAP3K9 | 1.24888813 |
| 38 | PDGFRA | 1.24324863 |
| 39 | CSNK1G2 | 1.23317673 |
| 40 | CDK8 | 1.20999098 |
| 41 | CSNK1G1 | 1.14016931 |
| 42 | KSR1 | 1.12209258 |
| 43 | MKNK1 | 1.09218457 |
| 44 | CSNK1A1L | 1.07862779 |
| 45 | ERBB4 | 1.06665413 |
| 46 | MINK1 | 1.04348013 |
| 47 | LATS2 | 1.02268958 |
| 48 | STK38 | 1.01763575 |
| 49 | MARK1 | 1.00645742 |
| 50 | TAOK3 | 0.98152401 |
| 51 | SGK3 | 0.97009959 |
| 52 | SGK494 | 0.95782691 |
| 53 | SGK223 | 0.95782691 |
| 54 | NEK1 | 0.94182377 |
| 55 | MAP3K6 | 0.94140270 |
| 56 | MOS | 0.92251382 |
| 57 | SRPK1 | 0.89925095 |
| 58 | CDK3 | 0.89351460 |
| 59 | GRK5 | 0.84854037 |
| 60 | CSNK1G3 | 0.83685971 |
| 61 | NEK6 | 0.83496613 |
| 62 | EPHA3 | 0.81612759 |
| 63 | CAMK2A | 0.79575858 |
| 64 | FGR | 0.79526247 |
| 65 | BMPR1B | 0.79349852 |
| 66 | WNK4 | 0.78617276 |
| 67 | YES1 | 0.77610739 |
| 68 | MAP3K2 | 0.77153370 |
| 69 | SCYL2 | 0.76966378 |
| 70 | CAMK1G | 0.76614460 |
| 71 | ERBB3 | 0.75753812 |
| 72 | BCR | 0.74663714 |
| 73 | NUAK1 | 0.73770347 |
| 74 | FGFR2 | 0.72906848 |
| 75 | SGK1 | 0.72505240 |
| 76 | NLK | 0.70381550 |
| 77 | MELK | 0.70247116 |
| 78 | SIK3 | 0.69562409 |
| 79 | PLK3 | 0.69498997 |
| 80 | TIE1 | 0.68713679 |
| 81 | TGFBR2 | 0.66768934 |
| 82 | FER | 0.64691001 |
| 83 | DYRK1A | 0.63912998 |
| 84 | WEE1 | 0.62057031 |
| 85 | PINK1 | 0.60904127 |
| 86 | PTK2 | 0.59874496 |
| 87 | PLK4 | 0.58985805 |
| 88 | OXSR1 | 0.58975947 |
| 89 | SIK2 | 0.58326656 |
| 90 | PRKCE | 0.58168223 |
| 91 | EPHB2 | 0.56494978 |
| 92 | LMTK2 | 0.56456610 |
| 93 | EIF2AK2 | 0.54825223 |
| 94 | PTK2B | 0.53931225 |
| 95 | PRKD3 | 0.53794777 |
| 96 | MST4 | 0.52078793 |
| 97 | PRKCQ | 0.50893798 |
| 98 | WNK1 | 0.50682598 |
| 99 | ROCK2 | 0.47479727 |
| 100 | PRKCG | 0.47383808 |
| 101 | PKN1 | 0.47151239 |
| 102 | WNK3 | 0.46930761 |
| 103 | ROCK1 | 0.45143975 |
| 104 | PAK3 | 0.44988602 |
| 105 | CSNK1D | 0.44981884 |
| 106 | PDK2 | 0.44836813 |
| 107 | PRKAA2 | 0.42940842 |
| 108 | PIK3CA | 0.42629562 |
| 109 | DYRK3 | 0.42508165 |
| 110 | PHKG2 | 0.42354097 |
| 111 | PHKG1 | 0.42354097 |
| 112 | BRSK1 | 0.42015953 |
| 113 | CSNK1E | 0.40815669 |
| 114 | FGFR3 | 0.40104534 |
| 115 | EGFR | 0.39831852 |
| 116 | ATM | 0.38551776 |
| 117 | CDK5 | 0.38490156 |
| 118 | RPS6KB1 | 0.38398660 |
| 119 | ERBB2 | 0.38142113 |
| 120 | PNCK | 0.37664136 |
| 121 | CAMK1D | 0.37556584 |
| 122 | CDK6 | 0.36783429 |
| 123 | ADRBK1 | 0.36760913 |
| 124 | PLK1 | 0.36741322 |
| 125 | RPS6KA4 | 0.36494648 |
| 126 | PRKAA1 | 0.36453715 |
| 127 | IGF1R | 0.35857162 |
| 128 | CDK12 | 0.35488534 |
| 129 | CAMK2B | 0.34415808 |
| 130 | KSR2 | 0.33650708 |
| 131 | PRPF4B | 0.33605269 |
| 132 | INSRR | 0.33105588 |
| 133 | STK24 | 0.32845692 |
| 134 | TTK | 0.32811772 |
| 135 | MUSK | 0.30647663 |
| 136 | MAPK12 | 0.30479918 |
| 137 | MAP3K7 | 0.30096025 |
| 138 | NTRK1 | 0.29809390 |
| 139 | PRKCZ | 0.28983964 |
| 140 | CAMK2D | 0.28441405 |
| 141 | CHEK2 | 0.28163526 |
| 142 | PAK6 | 0.28053721 |
| 143 | ZAK | 0.27446094 |
| 144 | CHUK | 0.26246576 |
| 145 | MARK2 | 0.24505710 |
| 146 | PDGFRB | 0.24375108 |
| 147 | RET | 0.24282782 |
| 148 | ADRBK2 | 0.24230232 |
| 149 | * MAPK10 | 0.24090762 |
| 150 | STK3 | 0.20638363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.11158357 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.26748292 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.74596019 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48415512 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.36636073 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.32433836 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22556314 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18293437 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96788034 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89930905 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89222730 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.86200905 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.85600230 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.85214549 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.81533483 |
| 16 | Long-term depression_Homo sapiens_hsa04730 | 1.80743899 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79682553 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.75289246 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75127393 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70976806 |
| 21 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.66693444 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64107220 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60966014 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.57452235 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.56242131 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.55635145 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51885620 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.45735769 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.44471570 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44372132 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41587093 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40225393 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32933605 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29259585 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25644374 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24715250 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24339247 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23986812 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21999541 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18848361 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18813094 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17484038 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16772770 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.16683485 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.15150353 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14603806 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.13949671 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13537036 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12323221 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08595891 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.08039414 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06768097 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06299107 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04660186 |
| 55 | Protein export_Homo sapiens_hsa03060 | 1.01361594 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00210092 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98566040 |
| 58 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.97778285 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97666343 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97163207 |
| 61 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.97107941 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95008491 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94321914 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.91822602 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91241234 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90865695 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89555505 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89491655 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88472762 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88418065 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86407810 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85923852 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85857724 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85251510 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84793583 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84637438 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84563856 |
| 78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84518003 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83144335 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82464292 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.78576875 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78392297 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78173995 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77534785 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77452060 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76461074 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75471102 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75174301 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.75084714 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73801002 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73410414 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.72748448 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71684530 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71648727 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71503883 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71345939 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70650826 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.69904094 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69174909 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67288073 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67269363 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65536478 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.65402048 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63878380 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63622784 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63619477 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.63590858 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63565155 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61737831 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61530524 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60308834 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60251971 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59774512 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58441062 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58413642 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58375771 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57449154 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56523669 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.55463498 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55433056 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.55099877 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.54653273 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54064448 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53954008 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53938012 |
| 126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53015760 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52487120 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52285232 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.51927016 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51818509 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49224317 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48925598 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48674412 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46467143 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44580127 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42973038 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40231062 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39527849 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39237497 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.39159894 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38308852 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37575061 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.36720867 |
| 144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36192235 |
| 145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35818792 |
| 146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35652488 |
| 147 | Melanoma_Homo sapiens_hsa05218 | 0.34867277 |
| 148 | Bile secretion_Homo sapiens_hsa04976 | 0.33364267 |
| 149 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32470551 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.31147451 |
| 151 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29068914 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27903611 |
| 153 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27530423 |
| 154 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27458233 |
| 155 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27276487 |
| 156 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25810783 |
| 157 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25293536 |
| 158 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25107738 |
| 159 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24184804 |
| 160 | Phagosome_Homo sapiens_hsa04145 | 0.23357289 |

